$0.96 EPS Expected for Steris PLC (STE)

October 13, 2017 - By Marie Mckinney

 $0.96 EPS Expected for Steris PLC (STE)
Investors sentiment increased to 1 in Q2 2017. Its up 0.43, from 0.57 in 2017Q1. It is positive, as 1 investors sold Steris PLC shares while 2 reduced holdings. 0 funds opened positions while 3 raised stakes. 406,945 shares or 38.42% more from 293,997 shares in 2017Q1 were reported.
Hanson Doremus Investment Mngmt invested 0.05% of its portfolio in Steris PLC (NYSE:STE). 12Th Street Asset Co Ltd Liability holds 2.18% or 103,863 shares. Prudential Plc owns 6,400 shares for 0% of their portfolio. California-based West Coast Financial Ltd has invested 2.19% in Steris PLC (NYSE:STE). Alphamark Ltd Llc reported 150 shares. Fruth reported 0.61% stake. Moreover, Gotham Asset Ltd Liability Company has 0.2% invested in Steris PLC (NYSE:STE). Ghp Inv Advsrs reported 18,410 shares or 0.24% of all its holdings. Yorktown Mgmt Company Inc stated it has 4,500 shares or 0.12% of all its holdings.

Analysts await Steris PLC (NYSE:STE) to report earnings on November, 1. They expect $0.96 EPS, up 7.87 % or $0.07 from last year’s $0.89 per share. STE’s profit will be $81.85M for 23.30 P/E if the $0.96 EPS becomes a reality. After $0.85 actual EPS reported by Steris PLC for the previous quarter, Wall Street now forecasts 12.94 % EPS growth. The stock decreased 1.23% or $1.11 during the last trading session, reaching $89.49. About 450,553 shares traded or 17.53% up from the average. Steris PLC (NYSE:STE) has risen 7.97% since October 14, 2016 and is uptrending. It has underperformed by 8.73% the S&P500.

Steris PLC (NYSE:STE) Ratings Coverage

Among 4 analysts covering Steris (NYSE:STE), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Steris had 5 analyst reports since November 2, 2015 according to SRatingsIntel. The stock of Steris PLC (NYSE:STE) earned “Buy” rating by Northcoast on Friday, June 3. The stock of Steris PLC (NYSE:STE) has “Outperform” rating given on Wednesday, August 9 by Raymond James. The firm earned “Neutral” rating on Wednesday, November 30 by Goldman Sachs.

STERIS plc provides infection prevention and other procedural services and products. The company has market cap of $7.63 billion. The Firm operates through four divisions: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical clients and others. It has a 64.1 P/E ratio.

More news for Steris PLC (NYSE:STE) were recently published by: Seekingalpha.com, which released: “STERIS Plc (STE) Q1 2018 Results – Earnings Call Transcript” on August 08, 2017. Seekingalpha.com‘s article titled: “STERIS Plc (STE) Q4 2017 Results – Earnings Call Transcript” and published on May 09, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com